Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Daniel E. Weiner"'
Autor:
Kenneth Abreo, Gideon Aweh, Doug Johnson, Andrew I. Chin, Reginald Gladish, Harold J. Manley, Dana C. Miskulin, Christos Argyropoulos, Vladimir Ladik, Daniel E. Weiner, Loay Salman, Caroline M Hsu, Eduardo Lacson, Jill Frament
Publikováno v:
American Journal of Kidney Diseases
Autor:
Allison C. Reaves, Daniel E. Weiner
Publikováno v:
American Journal of Kidney Diseases. 78:907-910
Publikováno v:
Clinical Pharmacology and Therapeutics
Most drug labels do not contain dosing recommendations for a significant portion of real-world patients for whom the drug is prescribed. Current label recommendations predominately reflect the population studied in pivotal trials that typically exclu
Autor:
Daniel E. Weiner, Suzanne Watnick
Publikováno v:
Kidney Medicine
Publikováno v:
Am J Kidney Dis
Autor:
Daniel E. Weiner, Kristine Almonte
Publikováno v:
Kidney Medicine
Kidney Medicine, Vol 2, Iss 6, Pp 681-683 (2020)
Kidney Medicine, Vol 2, Iss 6, Pp 681-683 (2020)
Due to extensive comorbid conditions, coronavirus disease 2019 (COVID-19) has a poor prognosis in people receiving maintenance hemodialysis. In this article, we describe our experience with 200 maintenance hemodialysis patients in a hemodialysis cent
Publikováno v:
Clin Pharmacol Ther
Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics
Despite legislation incentivizing and requiring drug companies to conduct pediatric clinical trials, there still is a 9-year delay in drug approval for pediatric labeling after the initial adult drug approval. The aim of this study was to review the
Autor:
Daniel E. Weiner, Pranav S. Garimella
Publikováno v:
J Am Soc Nephrol
BACKGROUND: Despite growth in value-based payment, attributes of nephrology care associated with payer-defined value remains unexplored. METHODS: Using national health insurance claims data from private preferred provider organization plans, we ranke
Publikováno v:
Kidney Medicine, Vol 2, Iss 6, Pp 810-811 (2020)
Kidney Medicine
Kidney Medicine
Autor:
Siah Kim, Samuel Fung, David Rosenbloom, Sobhana Thangaraju, Anthony N. Warrens, Daniel E. Weiner, Jonathan C. Craig, Nicholas Larkins, Kirsten Howard, Caren Rose, Peter P. Reese, Lorna Marson, Ronald D. Perrone, Nicole Evangelidis, Ling Xin Chen, Klemens B. Meyer, Klemens Budde, Bénédicte Sautenet, Angelique F. Ralph, Maggie K.M. Ma, Timothy L. Pruett, John S. Gill, Jessica Ryan, Germaine Wong, Allison Tong, Jeremy R. Chapman, Angela Ju, Michelle A. Josephson, Lionel Rostaing, Martin Howell, Jenny I. Shen, Camilla S. Hanson
Publikováno v:
Web of Science
Transplantation, vol 101, iss 8
Transplantation
Transplantation, 2017, 101 (8), pp.1887-1896. ⟨10.1097/TP.0000000000001774⟩
Publons
Transplantation, vol 101, iss 8
Transplantation
Transplantation, 2017, 101 (8), pp.1887-1896. ⟨10.1097/TP.0000000000001774⟩
Publons
International audience; BACKGROUND: Treatment decisions in kidney transplantation requires patients and clinicians to weigh the benefits and harms of a broad range of medical and surgical interventions, but the heterogeneity and lack of patient-relev